4.8 Review

Immunogenic Cell Death Induction by Ionizing Radiation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Chemistry, Multidisciplinary

Recent Advances in Hyperthermia Therapy-Based Synergistic Immunotherapy

Mengyu Chang et al.

Summary: Hyperthermia therapy has emerged as a strategy against malignant tumors, particularly when combined with nanomaterial-based photothermal therapy or magnetic hyperthermia. While these treatments alone may not completely cure cancer, when combined with cancer immunotherapy, they have shown potential for enhanced therapeutic outcomes against both primary tumors and metastatic lesions, as well as preventing cancer recurrence and prolonging survival period.

ADVANCED MATERIALS (2021)

Article Chemistry, Multidisciplinary

An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer

Lili Wang et al.

Summary: The Ir1 iridium complex induces immunogenic cell death in non-small cell lung cancer cells, triggering an anti-tumor T-cell response and resulting in long-lasting anti-tumor immunity through the activation of ICD. Ir1 is the first Ir-based complex capable of developing an immunomodulatory response by inducing immunogenic cell death.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Oncology

Therapeutic enhancement of radiation and immunomodulation by gold nanoparticles in triple negative breast cancer

Branislava Janic et al.

Summary: Gold nanoparticles have shown to enhance the efficacy of cancer radiotherapy by localizing radiation energy in tumors, leading to improved cell death. The size of nanoparticles plays a role in this enhancement, with different sizes affecting intracellular targeting and immunological responses.

CANCER BIOLOGY & THERAPY (2021)

Review Biochemistry & Molecular Biology

The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses

Tania Love Aaes et al.

Summary: Modern cancer therapies often combine cytotoxic strategies with immune activation to stimulate an antitumor response. Studying the interaction between antitumor cytotoxic therapies, cancer cells, and the immune system requires appropriate experimental tumor models. In this review, the focus is on the immunostimulatory and immunosuppressive properties of cancer cell lines used in immunogenic cell death studies.

CELL DEATH AND DIFFERENTIATION (2021)

Review Cell Biology

The role of toll-like receptor 4 (TLR4) in cancer progression: A possible therapeutic target?

Bahareh Kashani et al.

Summary: The TLR family is crucial for pattern recognition in innate immunity, with TLR4 playing a significant role in inflammatory diseases and cancer. Aberrant expression of TLR4 in tumors is closely associated with tumorigenesis, progression, and drug resistance. TLR4 inhibitors show promise in cancer therapy.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Oncology

Enhancement of cisplatin sensitivity in human breast cancer MCF-7 cell line through BiP and 14-3-3ζ co-knockdown

Tahereh Kashkoulinejad-Kouhi et al.

Summary: Cisplatin resistance in MCF-7 cells is enhanced by downregulating BiP and 14-3-3 zeta proteins to promote apoptosis, activating UPR to counteract apoptotic pathways and increase sensitivity to cisplatin.

ONCOLOGY REPORTS (2021)

Article Multidisciplinary Sciences

Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress

Zhusheng Huang et al.

Summary: The study demonstrates a strategy of using gadolinium-based nanoscale coordination polymers to enhance radiation-induced immunogenic cell death, thereby boosting anti-tumor immune responses.

NATURE COMMUNICATIONS (2021)

Article Engineering, Biomedical

Recent Progress in the Synergistic Combination of Nanoparticle-Mediated Hyperthermia and Immunotherapy for Treatment of Cancer

Zachary R. Stephen et al.

Summary: Immunotherapy has shown success in certain cancers, and combinational approaches with hyperthermia therapy are being explored to enhance its effectiveness. Nanoparticle-based hyperthermia increases tumor immunogenicity and permeability, particularly effective in solid tumors.

ADVANCED HEALTHCARE MATERIALS (2021)

Editorial Material Oncology

Ferroptosis becomes immunogenic: implications for anticancer treatments

Daolin Tang et al.

Summary: Ferroptosis is an iron-dependent form of non-apoptotic cell death that has been shown to have antitumor immune effects, inducing immunogenic cell death by emitting DAMPs and triggering dendritic cell maturation in vitro. Furthermore, ferroptotic cells are capable of vaccinating against fibrosarcoma rechallenge in preclinical models.

ONCOIMMUNOLOGY (2021)

Review Cell Biology

Calreticulin-Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients

Michal Kielbik et al.

Summary: Immunogenic cell death (ICD), characterized by features of necroptosis and apoptosis, plays a crucial role in eliminating tumor cells through inducing an adaptive immune response. The focus of the research is on the involvement of CRT in ICD and its expression on ovarian cancer cells, as well as its prognostic and predictive value in ovarian cancer patients.
Review Biochemistry & Molecular Biology

Proton and Heavy Particle Intracranial Radiosurgery

Eric J. Lehrer et al.

Summary: Stereotactic radiosurgery (SRS) delivers a highly conformal ablative dose of radiation to both benign and malignant targets, traditionally in a single fraction but also using fractionated approaches for larger lesions. Photon-based methods have been effective, but advancements are sought for improved dose precision and radiobiologic effect, with particle-based techniques showing promise in reducing toxicity risks and increasing biological effectiveness. Studies on proton radiosurgery for brain metastases have shown promising results, with further prospective research needed to validate safety and efficacy.

BIOMEDICINES (2021)

Article Gastroenterology & Hepatology

Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study

Gyu Sang Yoo et al.

Summary: In a murine model of HCC, combining radiation therapy and immunotherapy enhanced the abscopal effect by inhibiting tumor growth and increasing infiltration of activated cytotoxic T cells.

CLINICAL AND MOLECULAR HEPATOLOGY (2021)

Review Oncology

Broadening horizons: the role of ferroptosis in cancer

Xin Chen et al.

Summary: Ferroptosis is an iron-dependent form of regulated cell death driven by excessive lipid peroxidation, and can be induced by various agents to suppress tumor growth while also potentially triggering inflammation-associated immunosuppression. The extent of ferroptosis's impact on tumor biology and its interactions with other signaling pathways are still under investigation.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Cell Biology

Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment

Vera M. Kho et al.

Summary: MDSCs are a heterogeneous population of immature immune cells that have suppressive functions in the tumor microenvironment. They play a role in promoting tumor growth by inhibiting the proliferation and function of immune effector cells. The effects of radiotherapy and cGAS/STING signaling on MDSC recruitment, expansion and function are explored in this review, highlighting the key role of cGAS and STING activation in generating systemic anti-tumor immunity after irradiation.

CELLULAR IMMUNOLOGY (2021)

Review Oncology

Agonistic CD40 Antibodies in Cancer Treatment

Dijana Djureinovic et al.

Summary: CD40 is a crucial costimulatory molecule in anti-tumor immunity, and agonists of this pathway have shown promising results in preclinical and clinical settings. The stimulation of CD40 leads to inflammation and enhanced immune response, making it a potential target for cancer treatment. Agonistic CD40 antibodies are currently being evaluated in early phase clinical trials, showing potential for enhancing the anti-tumor activity of other systemic therapies.

CANCERS (2021)

Review Cell Biology

Biomarkers of Radiotherapy-Induced Immunogenic Cell Death

Rianne D. W. Vaes et al.

Summary: Radiation therapy can induce immunogenic cell death and release various immunogenic factors, but the search for biomarkers predicting immunogenic cell death in tumor cells remains limited. This review summarizes the available literature on potential biomarkers of radiation-induced immunogenic cell death evaluated in cancer patients and discusses their clinical relevance.
Article Oncology

CLTRN, Regulated by NRF1/RAN/DLD Protein Complex, Enhances Radiation Sensitivity of Hepatocellular Carcinoma Cells Through Ferroptosis Pathway

Yin Yuan et al.

Summary: CLTRN is a crucial regulator of radiation sensitivity in hepatocellular carcinoma, associated with ferroptosis and potentially serving as a novel therapeutic target or prognostic marker in HCC treatment.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Review Oncology

Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?

Thijs A. van Schaik et al.

Summary: Depending on the genetic composition of tumor cells and treatment variables of conventional therapies, specific cell death pathways are activated which in turn influence the tumor microenvironment and immune cell response post-treatment.

FRONTIERS IN ONCOLOGY (2021)

Article Medicine, Research & Experimental

Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer

Zheng Zhang et al.

Summary: The study showed that iron-saturated Lactoferrin (Holo-Lf) can induce ferroptosis in triple-negative breast cancer cells and enhance their sensitivity to radiotherapy. Conversely, low iron-saturated Lactoferrin (Apo-Lf) may inhibit this cell death process. Non-triple-negative breast cancer cells may have resistance to Holo-Lf-induced ferroptosis due to higher redox balance capacity.

THERANOSTICS (2021)

Article Biochemistry & Molecular Biology

Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers

Ling F. Ye et al.

ACS CHEMICAL BIOLOGY (2020)

Review Immunology

Immunological impact of cell death signaling driven by radiation on the tumor microenvironment

Maria Esperanza Rodriguez-Ruiz et al.

NATURE IMMUNOLOGY (2020)

Review Cell Biology

Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer

Joseph Sia et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Chemistry, Multidisciplinary

Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy

Jing Gao et al.

ACTA PHARMACOLOGICA SINICA (2020)

Review Oncology

Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology

Isaure Vanmeerbeek et al.

ONCOIMMUNOLOGY (2020)

Review Oncology

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Lorenzo Galluzzi et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Chemistry, Multidisciplinary

MnOxNanospikes as Nanoadjuvants and Immunogenic Cell Death Drugs with Enhanced Antitumor Immunity and Antimetastatic Effect

Binbin Ding et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Review Oncology

Ferroptosis, necroptosis, and pyroptosis in anticancer immunity

Rong Tang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Review Biotechnology & Applied Microbiology

HMGB1 in Radiotherapy: A Two Headed Signal Regulating Tumor Radiosensitivity and Immunity

Yin Liao et al.

ONCOTARGETS AND THERAPY (2020)

Article Immunology

Damage-associated molecular patterns in tumor radiotherapy

Milad Ashrafizadeh et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2020)

Review Biochemistry & Molecular Biology

The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer

Quinn Storozynsky et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Chemistry, Multidisciplinary

Rationally Designed Redox-Active Au(I) N-Heterocyclic Carbene: An Immunogenic Cell Death Inducer

Sajal Sen et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Review Oncology

Targeting immunogenic cell death in cancer

Asma Ahmed et al.

MOLECULAR ONCOLOGY (2020)

Review Cell Biology

Detection of immunogenic cell death and its relevance for cancer therapy

Jitka Fucikova et al.

CELL DEATH & DISEASE (2020)

Review Immunology

Enhancing the efficacy of immunotherapy using radiotherapy

Synat Keam et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)

Review Oncology

Radiation biology considerations of proton therapy for gastrointestinal cancers

Chris Beltran et al.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)

Review Chemistry, Multidisciplinary

Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy

Xiaopin Duan et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)

Review Biochemistry & Molecular Biology

Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy

Bernardo L. Rapoport et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Multidisciplinary Sciences

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy

Weimin Wang et al.

NATURE (2019)

Review Cell Biology

Immunogenic cell death in cancer therapy: Present and emerging inducers

Jingyi Zhou et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Article Oncology

Immunotherapy and Radiation Charting a Path Forward Together

Vishwajith Sridharan et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2019)

Article Multidisciplinary Sciences

Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma

Friederike Laemmer et al.

PLOS ONE (2019)

Article Chemistry, Multidisciplinary

Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy

Qian Chen et al.

ADVANCED MATERIALS (2019)

Review Biochemistry & Molecular Biology

An emerging role for nanomaterials in increasing immunogenicity of cancer cell death

Tatiana Mishchenko et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)

Review Oncology

Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion

Jose Pedro Friedmann Angeli et al.

NATURE REVIEWS CANCER (2019)

Review Pharmacology & Pharmacy

Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy

Flavia Radogna et al.

BIOCHEMICAL PHARMACOLOGY (2018)

Article Biochemistry & Molecular Biology

eIF2α phosphorylation is pathognomonic for immunogenic cell death

Lucillia Bezu et al.

CELL DEATH AND DIFFERENTIATION (2018)

Review Oncology

Autophagy-regulating microRNAs: potential targets for improving radiotherapy

Hongbin Li et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)

Review Chemistry, Multidisciplinary

P2RX7 Purinoceptor as a Therapeutic Target-The Second Coming?

Chris N. J. Young et al.

FRONTIERS IN CHEMISTRY (2018)

Review Immunology

Necroptotic cell death in anti-cancer therapy

Olga Krysko et al.

IMMUNOLOGICAL REVIEWS (2017)

Review Immunology

The renaissance of anti-neoplastic immunity from tumor cell demise

Yuting Ma et al.

IMMUNOLOGICAL REVIEWS (2017)

Review Biochemistry & Molecular Biology

Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation

A. D. Garg et al.

CELL DEATH AND DIFFERENTIATION (2016)

Article Oncology

Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

Michael B. Bernstein et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Review Oncology

Roles of low-density lipoprotein receptor-related protein 1 in tumors

Peipei Xing et al.

CHINESE JOURNAL OF CANCER (2016)

Article Oncology

Antitumor Immunity Induced after α Irradiation

Jean-Baptiste Gorin et al.

NEOPLASIA (2014)

Article Biochemistry & Molecular Biology

Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells

Petra Schildkopf et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)